The document discusses tumours of the pharynx, including benign and malignant tumours of the nasopharynx and oropharynx. In the nasopharynx, juvenile nasopharyngeal angiofibroma is the most common benign tumour seen in adolescent males. Nasopharyngeal carcinoma is the most common malignancy and is strongly associated with Epstein-Barr virus. In the oropharynx, common benign tumours include mucous retention cysts and papillomas, while squamous cell carcinoma is the most frequent malignancy, associated with risk factors like smoking, alcohol, and HPV 16.
3. Juvenile Nasopharyngeal Angiofibroma
Histologically benign but locally aggressive vascular tumour occupying nasopharynx seen in
adolescent males causing recurrent unprovoked episodes of epistaxis
Incidence 0.05 to 0.1% of head & neck cancers
Etiology
Age gp – 10 – 25 years of age, adolescents (mc), regresses/ stops growing after 25 yrs of age
Sex – males (exclusive)
Nasal erectile vascular tissue(hamartomatous nidus of inf turbinate tissue) mislocated in
nasopharynx -> gets activated when testosterone acts on it -> NPA
Abnormal growth of nasopharyngeal fibrocartilage/ fibrovascular stroma
Origin from non chromaffin preganglionic cells of terminal branches of maxillary artery
4. Genetic/ Heredity
Trauma
Infection
Allergy
Pathology
Contains both vascular and fibrous tissue
Covered with nasopharyngeal mucosa – deceives vascularity
Pink grey or purple red colour, sessile or pedunculated
No capsule – invades locally
Thin walled vessels just endothelial lined, no muscular coat – bleeding which cant be controlled by
adrenaline
5. Extension
Origin – above sup margin of sphenopalatine foramen in lat wall of nasopharynx,
attached to roof of choana, post part of middle turbinate, post part of nasal septum
Locally invasive
Anteriorly – nasal cavity, orbit
Posteriorly – destroys pterygoid plates, extends to vidian nerve
Superiorly – sphenoid sinus->cavernous sinus, middle cranial fossa
Sphenoid sinus -> post ethmoids, ant cranial fossa
Laterally -> pterygopalatine fossa -> maxillary sinus -> infratemporal fossa -> cheek
6. Clinical features
Nasal
U/L gradually increasing nasal obstruction, later B/L
Recurrent painless unprovoked episodes of nasal bleed
Nasal discharge
Loss of smell
Mouth breathing/ snoring
Rhinolalia clausa
Ear
Blockage in ear due to ET blockage leading to serous otitis media and conductive hearing loss,
otalgia, tinnitus
7. Eyes
Pain, proptosis, lacrimation, diplopia, rarely blindness
Face
Cheek swelling, broadening of nasal bridge, frog face deformity
CNS
II CN – blindness
III, IV, VI CN – diplopia
V CN – neuralgic pain
Increased intracranial pressure – headache, blurring of vision, projectile vomiting
General – Anaemia, sexual underdevelopment
NO LYMPH NODE INVOLVEMENT
8. Signs
Post rhinoscopy
Pink, purple, reddish globular sessile lobulated mass, firm in consistency obstructing
one or both choana, may be visible below nasopharyngeal isthmus
Ant rhinoscopy
Globular pinkish mass in post part of nasal cavity, septum deviated to opposite side
NO PROBE TEST, NO DIGITAL PALPATION
Oral cavity – soft palate bulge
D/D – Infected AC polyp, carcinoma, rhinosporodiosis, craniopharyngioma
9. Diagnosis
Clinical
DNE
Biopsy – Only excision biopsy
Radiology
X ray soft tissue nasopharynx lateral view – soft tissue in NP
CT Scan with contrast – gold standard
Vascular dumb bell shaped tumour in nasal cavity, nasopharynx, pterygopalatine foramen
Anterior bowing of posterior wall of maxillary sinus and post bowing of pterygoids – Holman Miller sign/
Antral sign
MRI – intracranial/ orbit extension
10. Digital Subtraction Angiography (DSA)/ Carotid angiography
Tumour can be seen
Also used to embolise feeding vessel on same side – internal maxillary artery
Materials used – gelfoam, PVA
Helps to reduce bleeding intraoperatively
Operate 24- 48 hours after embolization
Always arrange blood transfusion before surgery
Other methods to reduce bleeding – estrogen therapy, pre op RT, cryotherapy
11. Staging Sessions/ Fisch ()
I A – limited to nasopharynx and nose (I)
I B – Extend to PNS (II)
II A – Minimal extension to pterygomaxillary fossa (II)
II B – Full occupation of pterygomaxillary fossa with bony erosion of orbit (II)
III A – Erosion of skull base with minimal intracranial extension (III)
III B – Extensive intracranial extension with extending to cavernous sinus, optic
chiasma, pituitary fossa (IV)
12. Treatment
Surgical excision – TOC
Complete excision
Approaches
Wilson’s transpalatal approach – Preferred if tumour limited to nose and nasopharynx – U
incision made at the junction of soft and hard palate – separation of hard and soft palate – part
hard palate removed for better exposure, complication – oroantral fistula
Lateral rhinotomy approach with medial maxillectomy – if extends beyond nasopharynx into
Sardana’s approach – transpalatine along with sublabial, extension to sublabial area
Endoscopic approach – endonasal – for small and medium sized tumours
13. Mid facial degloving approach – good cosmetic results
Le fort’s type I osteotomy/ trans maxillary approach - extension to PNS,
pterygopalatine fossa
Biller’s transmandibular lip splitting approach – infratemporal fossa, pterygoid muscles
Craniotomy
Other modalities
RT – advanced disease, intracranial extension
Complication – osteoradionecrosis, secondary malignancies, cataract, optic atrophy
High recurrence with RT
14. CT
Very aggressive tumours
Doxorubicin, Vincristine
Prognosis
Early diagnosis -> good prognosis
16. Nasopharyngeal Carcinoma
Incidence – 2% of malignancies of head and neck
Age group – Bimodal – 10 -20 years (more aggressive), 50 – 70 years
M:F = 3:1
MC in Chinese/ mongoloids – south china, Taiwan, Indonesia, Hong kong, Thailand, Malaysia, NE India
mainly Nagaland
Etiology
Enviromental factors – Air pollution, wood burning, incense sticks smoke, chemical fumes inhalation,
exposure to nickel, chromium, radioactive material, polycystic hydrocarbons, household smoke and fumes
Dietary ingestion of nitrosamines in form of salted fish, smoked food, Chinese herbal medicine usage,
alcohol, smoking, tobacco, opium
Vitamin C deficiency
Genetic – chromosomal abnormalities
17. EB Virus – increased antibody titres – in 90% especially undifferentiated/ poorly differentiated
cancers
Pathology
Proliferative type – Nasal obstruction
Ulcerative type – epistaxis
Infiltrative type – CN involved, invasive
Histological classification
Type I – well differentiated keratinizing scc – 25%
Type II – differentiated non keratinizing – 12%
Type III – undifferentiated/ anaplastic non keratinizing – 63%
Type II and III – transitional cell carcinoma, lymphoepithelioma
18. Spread
MC site of origin – fossa of rosenmuller in lateral wall of nasopharynx
Superiorly – intracranial cavity by destruction of basisphenoid and basiocciput
Laterally – parapharyngeal space, infratemporal fossa
Anteriorly – Nasal cavity, PNS, orbit
Inferiorly – oropharynx, soft palate
Lymphatic – early lymphatic spread, B/L involvement common in advance cases,
retropharyngeal and parapharyngeal lymph nodes to upper deep cervical and posterior
group of lymph nodes
CN – VI (1st nerve involved), V, IX, X, XI, XII
Haematogenous – Bone (Spine, shoulder, pelvis, skull), liver and lungs
19. C/F
Cervical – Lump in neck – 60-80%, 50% B/L –MC symptom
Ear – Hearing loss (CHL) U/L due to SOM unresolving associated with otalgia, tinnitus, giddiness
due to ET blockage – 2nd MC symptom
Nose – Nasal obstruction (u/l or b/l) associated with blood stained nasal discharge and foul smell
– 3rd MC symptom, rhinolalia clausa
Epistaxis
Eye – diplopia (VI CN), epiphora, proptosis, loss of corneal reflex, diminished vision
CNS – headache (V CN), ophthalmoplegia (III,IV and VI CN), Neck and facial pain (V CN), jugular
foramen syndrome (IX, X, XI CN), exophthalmos and blindness (II CN), horner’s syndrome (cervical
sympathetic chain)
Weight loss, loss of appetite
20. L/E
Pharyngeal – palatal swelling or soft palate bulge
Post rhinoscopy – diffuse bulge or ulceroproliferative growth in nasopharynx
Ant rhinoscopy – mass in nose, friable, bleeds on touch, blood stained discharge
Trotter’s triad
Conductive hearing loss (ET blockage), I/L temporo parietal/ mandibular pain – V
CN, Soft palate paralysis/ decreased mobility – X CN
Trismus – pterygoid muscles
21. Diagnosis
Pan endoscopy – to rule out 2nd tumour
DNE, PTA, Tympanogram
Biopsy under vision
FNAC
CT Scan – HRCT Neck and Nasopharynx – toc
MRI
CT Lung, Abdomen, Chest X Ray
USG abdomen
Bone Scan
Serology - EBV
22. TNM Staging
T1 – Nasopharynx
T2a – Oropharynx, Nasal cavity without parapharyngeal spread
T2b – With parapharyngeal spread
T3 – Bony structures, PNS
T4 – Intracranial, CN, infratemporal fossa
N1 – I/L LN upto 6 cm
N2 – C/L or B/L LN upto 6 cm
N3a – Any LN > 6 cm
N3b – Involves supraclavicular fossa
Supraclavicular fossa / Ho’s triangle – clavicle medially and laterally, where neck meets the shoulder
23. Staging
I – T1
II A – T2a
II B – T2b or N1
III – T3 or N2
IV A – T4
IV B – N3
IV C – M1
24. Treatment
RT - TOC
External beam RT – 6000 - 7000 rads
Main treatment
Stage III and IV – RT and CT
5 FU and cisplatin
Residual/ recurrence
RND
2nd dose of external RT
Brachytherapy
Surgery
25. Surgical approaches
Fisch approach
Biller’s approach
Maxillary swing approach
Nasopharyngectomy
Prognosis
Stage III and IV – RT more effective – good prognosis
Early diagnosis – good prognosis
26. Tumours of Oropharynx
Benign tumours
Mucous retention cyst – Vallecula, yellowish – pedunculated or sessile smooth
cyst
Most of the patients are asymptomatic with accidental finding on examination
Few – foreign body sensation in throat
Treatment
If pedunculated – excision
If cystic – marsipulization ( incision and drainage with removal of cyst wall)
27. Papilloma – Seen over tonsils, soft palate, faucial pillars – pedunculated
Asymptomatic or local irritation of throat
Treatment – excision
Pleomorphic adenoma – Hard palate, soft palate, treatment – excision
Haemangioma – Palate, tonsil, post pharyngeal wall, congenital, females,
regresses after age of 2 years
Dysphagia, bleeding
If persists after 3 years – surgical resection, cryotherapy, coagulation by LASER,
diathermy
28. Malignancy of oropharynx
Etiology
Common in South Asia, Males, age group 50 – 70 years
Alcohol
Smoking
Betelnut chewing
Poor orodental hygiene
Atmospheric pollution
HPV 16 – SCC Tonsil
29. Types
SCC – 90%
Lymphoma – 20% (Tonsils) – Non Hodgkin’s lymphoma
Minor salivary gland tumours – soft palate, hard palate, pillars –
ca, adenoid cystic ca
Sites
Lateral wall – MC – Tonsils 50%
Base of tongue & Vallecula – 2nd MC – 40%
Post pharyngeal wall – 10%
30. C/F
Associated with lymph node swelling
Early symptoms
Neck swelling, throat irritation, burning sensation with acidic food, lump in throat
Late symptoms
Dysphagia, odynophagia, dysarthria, hot potato voice, trismus
Other symptoms
Unilateral referred otalgia, ulcer in throat, increase salivation, drooling of saliva,
muffled speech, neck pain, oral bleed, hemoptysis
31. Signs
Ulcerative lesion/ endophytic lesion – base of tongue, vallecula
Exophytic/ Proliferative lesion – tonsillar fossa, soft palate, post pharyngeal wall
IDL examination – base of tongue, vallecula, tonsillo lingual sulcus
Digital palpation
Post rhinoscopy – nasopharyngeal surface of soft palate
Tongue movements restricted, deviation of tongue
Lymph node enlargement – I, II, III. IV, V, base of tongue lesions (70%) can be B/L
mainly JD LN, Post pharyngeal wall 60% can be B/L, Tonsils 50% mainly JD, Faucial
– LN Ib, II
32. Distant Metastasis
Bone, liver, lung
TNM Staging
T staging
Tx , Tis
T1 – upto 2 cm, T2 - > 2 upto 4cm, T3 - > 4 cm
T4a – involves surrounding structures – muscles of tongue, larynx, hard palate, mandible, medial
pterygoids
T4b – involves lateral pterygoids, nasopharynx, skull base, carotid
N
M
33. Stage I – T1, Stage II – T2, Stage III – T3 or N1, Stage IV a – T4a or N2, Stage IV b – T4b or N3,
Stage IV c – M1
Diagnosis
Biopsy – punch biopsy , under GA if trismus, hidden areas
Excisional biopsy – lymphomas (tonsillectomy)
Pan endoscopy – secondary primary
FNAC – LN
USG Neck – LN
X Ray Mandible/ OPG
Chest X Ray
CT Scan with contrast, MRI, PET Scan
34. D/D – Tuberculosis ulcer, syphilis, Vincent’s angina. Quinsy
Treatment
Surgery – local excision and neck dissection
RT
CT
Combined
Palliative – advanced tumours – pain relief, tracheostomy, gastrostomy
Prognosis – poor as late presentation
35. Early stage – RT, organ preservation, laser excision
If N0 – Selective neck dissection, N1 – RND
Advanced stage – surgical resection along with mandibulectomy along with RND
(COMMANDO operation) followed by post operative RT
Concurrent CT RT
Tonsillar fossa
B/L Neck dissection may be required
36. Lymphomas
B cell high grade Non Hodgkin’s lymphoma
M:F 2:1, children and young adults
Site – tonsil (mc), base of tongue
EBV associated with it
Smooth bulky mass, U/L swelling of tonsil
Treatment – RT, RT and CT
38. Etiology
Alcohol (mc)
Smoking
Genetic
Radiation
Plummer vinson syndrome/ Patterson brown Kelly syndrome/ sideropenic
anaemia – hypochromic microcytic iron deficiency anaemia – POST CRICOID
Low socio economic status
39. Age group > 50 yrs, male – commonest cause of dysphagia in elderly male
Post cricoid – females, 20 – 40 yrs age
Pathology
Proloferative/ exophytic/ cauliflower like – post pharyngeal wall
Ulcerative/ endophytic
Ulceroproliferative
Microscopy
Well differentiated (mc), moderately differentiated, poorly differentiated, anaplastic
Spread – lymphatic, direct, hematogenous
40. Lymphatic spread
Pyriform sinus – 75% chance of lymph node spread, 30% B/L, LEVEL II and III
Post cricoid – 20% chance of lymph node spread, B/L common, paratracheal
lymph node, IV, VI, VII
Post pharyngeal wall – 40% chance of lymph node spread, RP LN (mc), IV
Hematogenous – lung, liver, bone
Direct – paraglottic space leading to fixation of vc, supraglottis, oropharynx,
cricopharyngeal sphincter, laryngeal cartilages, thyroid gland
41. C/F
Progressive dysphagia more to solids for more than 1 month. Dysphagia is a late symptom but early in
post cricoid malignancy
Neck swelling
Sticking of food in throat, lump in throat (1st symptom), FB sensation in throat, pricking sensation in
throat
Hoarseness
Stridor
Choking spells, shortness of breath, aspiration
Referred otalgia
Spitting of blood
Odynophagia/ pain in neck – late symptom
42. Signs
IDL
Ulcerative/ proliferative growth
Pooling of saliva – post cricoid malignancy
Fixed VC
Oedema/ erythema of arytenoids/ post cricoid area – post cricoid malignancy
Neck – LN metastasis
Widening and splaying of larynx
Larynx pushed forwards – post cricoid malignancy
Laryngeal crepitus absent – post cricoid malignancy
43. Diagnosis
X Ray Neck – AP/Lat – cartilage erosion, pre vertebral widening, airway patency
Chest X ray – mediastinal widening, aspiration pneumonia, secondaries
Barium swallow with fluoroscopy – oesophagus, upper esophageal sphincter
FNAC
DL Scopy/ hypopharyngoscopy and biopsy
CECT – primary modality, cartilage invasion
PET – recurrent, residual disease, distant metastasis
MRI
44. TNM Staging
T1 – limited to one site of hypopharynx and upto 2 cm
T2 – Greater than 1 site or > 2 cm without fixation of larynx
T3 – Greater than 4 cm with fixation of larynx
T4a – involves thyroid, cricoid cartilage, thyroid gland, oesophagus, supraglottis,
cricopharyngeal sphincter
T4b – involves prevertebral, carotid, mediastinum
N
M
STAGING
45. Treatment
Early stage – RT
Advanced stage – Surgery and post op RT
CT – adjuvant/ palliative
Surgery –
Early stage – laser excision, partial pharyngectomy, partial laryngopharyngectomy
Late stage – total laryngo pharyngo esophagectomy with gastric pull up/ colonic transposition
Reconstruction – PMMC flap, free flaps – radial forearm, lateral thigh, enteric flaps – jejunal ,
omental
Neck dissection – selective (N0), RND
46. Prognosis
Early diagnosis – rare - good prognosis – 80% 5 year survival
Late diagnosis – poor prognosis – 30% 5 year survival
Post cricoid malignancy – poor prognosis – early B/L LN metastasis, vertebral
column spread